文献速递间质性肺疾病

间质性肺疾病住院率:肺纤维化基金会注册数据分析

Hospitalization Rates in Interstitial Lung Disease: An Analysis of the Pulmonary Fibrosis Foundation Registry.
PubMed 文献 · Am J Respir Crit Care Med · 2024-01-01

基于肺纤维化基金会患者注册数据,分析不同类型间质性肺疾病(ILD)的住院率及住院与结局的关联。各ILD亚型住院率相似,特发性肺纤维化(IPF)为40.6%,结缔组织病相关ILD为42.8%,非IPF特发性间质性肺炎为44.9%,慢性过敏性肺炎为46.5%,其他ILD为53.3%。调整合并症和疾病严重度后,全因住院与无移植生存率降低无关,但呼吸相关住院与无移植生存率降低相关。

要点

  • 各ILD亚型住院率相似,IPF为40.6%,其他ILD最高达53.3%。
  • 呼吸相关住院与无移植生存率降低独立相关(AHR 1.53)。
  • CTD-ILD和非IPF IIP住院后死亡风险低于IPF。

核心结论

  • 各ILD亚型住院率相似。
  • CTD-ILD和非IPF IIP患者住院后死亡或移植风险低于IPF患者。
  • 在混合ILD人群中,全因住院与无移植生存率降低无关,但呼吸相关住院与无移植生存率降低相关。

研究设计与样本

  • 对肺纤维化基金会患者注册数据的分析。
  • 比较不同ILD类型的住院率和住院后生存率。

主要发现

  • 住院率:IPF 40.6%,CTD-ILD 42.8%,非IPF IIP 44.9%,CHP 46.5%,其他ILD 53.3%。
  • 调整合并症和疾病严重度后,全因住院与无移植生存率降低无关(AHR 1.20;95%CI 0.98,1.46;P=0.0759)。
  • 呼吸相关住院与无移植生存率降低相关(AHR 1.53;95%CI 1.23,1.90;P=0.0001)。
  • 与IPF相比,CTD-ILD住院后死亡风险更低(HR 0.43;95%CI 0.25,0.75;P=0.0031),非IPF IIP也更低(HR 0.3;95%CI 0.15,0.58;P=0.005)。
  • CHP(HR 0.67;95%CI 0.37,1.20;P=0.1747)和其他ILD(HR 0.54;95%CI 0.19,1.54;P=0.25)住院后死亡风险与IPF相当。

临床怎么用

  • 临床应关注ILD患者呼吸相关住院,因其与无移植生存率降低独立相关。
  • IPF患者住院后死亡或移植风险高于CTD-ILD和非IPF IIP患者,需加强随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Little is known about hospitalization in other types of interstitial lung disease (ILD) besides idiopathic pulmonary fibrosis (IPF). Objectives: To determine the frequency of hospitalizations in various types of ILD and elucidate the association of hospitalization with outcomes. Methods: An analysis of the Pulmonary Fibrosis Foundation Patient Registry data was performed. Inpatient hospitalization rates and survival posthospitalization were compared for various types of ILD. Measurements and Main Results: Hospitalization rates were similar across ILD types: 40.6% of participants with IPF, 42.8% of participants with connective tissue disease-related ILD (CTD-ILD), 44.9% of participants with non-IPF idiopathic interstitial pneumonia (IIP), 46.5% of participants with chronic hypersensitivity pneumonitis (CHP), and 53.3% of participants with "other" ILD. All-cause hospitalization was not associated with decreased transplant-free survival (adjusted hazard ratio [AHR], 1.20; 95% confidence interval [CI] = 0.98, 1.46; P = 0.0759) after adjusting for comorbidities and severity of illness; however, respiratory-related hospitalization was (AHR, 1.53; 95% CI = 1.23, 1.90; P = 0.0001). Participants with CTD-ILD (HR, 0.43; 95% CI = 0.25, 0.75; P = 0.0031) and non-IPF IIP (HR, 0.3; 95% CI = 0.15, 0.58; P = 0.005) had a lower risk of death posthospitalization compared with those with IPF, whereas those with chronic hypersensitivity pneumonitis (HR, 0.67; 95% CI = 0.37, 1.20; P = 0.1747) or other ILD (HR, 0.54; 95% CI = 0.19, 1.54; P = 0.25) had a risk comparable with that for IPF. Conclusions: Rates of hospitalization are similar across ILD subtypes. The risk of death or transplant after posthospitalization is lower in patients with CTD-ILD and non-IPF IIP, compared with patients with IPF. In a mixed population of participants with ILD, all-cause hospitalizations were not associated with decreased transplant-free survival; however respiratory-related hospitalizations were.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. King CS, Ignacio RV, Khangoora V, et al. Hospitalization Rates in Interstitial Lung Disease: An Analysis of the Pulmonary Fibrosis Foundation Registry. Am J Respir Crit Care Med. 2024. PMID: 38236191. doi:10.1164/rccm.202309-1708OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。